Affiliation:
1. Surgut State University
2. Surgut Regional Clinical Hospital
Abstract
The aim of the study is to determine the significance of hyperammonemia for the diagnosis of non-alcoholic fatty liver disease (NAFLD) in patients with metabolically associated comorbid pathology.
Materials and Methods. A single-stage cohort randomized study was conducted to examine NAFLD in patients with metabolically associated pathology – type 2 diabetes, obesity, hypertension, coronary artery disease, and dyslipidemia. The study included 96 patients, who were divided into 3 groups: patients with steatotic liver disease (n=33), patients with non-alcoholic steatohepatitis (n=47) and patients with newly diagnosed liver cirrhosis (n=16). For NAFLD diagnosis, non-invasive methods were also applied (APRI, FIB4, NAFLD fibrosis score). To diagnose hepatocellular insufficiency, the authors evaluated ammonia level in capillary blood. Statistical processing was carried out by parametric and nonparametric methods, correlation and cluster analysis (Statistica 10.0). We also calculated odds ratio.
Results. Metabolic syndrome in patients aged 64.2±0.85 (64.9 % females and 35.1 % males, Charleson comorbidity index 4.57±0.12) was represented by type 2 diabetes (100 %), insulin-treated diabetes (2/3 of patients), hypertension (1/3 of patients, stage 3 of NAFLD), obesity (87.5 %), coronary heart disease (90.6 %), steatotic liver disease (34.4 %), non-alcoholic steatohepatitis (49 %) and asymptomatic liver cirrhosis (16,6 %). According to NFS results, stage F3–F4 fibrosis was diagnosed in 52.1 % of patients, F2 fibrosis in 47.9 %; hyperammonemia was found in 91.7 % (up to 111.1±4.86 (101.3–120.7) µmol/l). Hyperammonemia developed from steatosis to non-alcoholic steatohepatitis and liver cirrhosis and correlated with the stage of liver fibrosis, hepatitis activity, and metabolic syndrome key criteria. NFS calculator and hyperammonemia diagnosis made it possible to stratify the stages of non-alcoholic fatty liver disease.
Publisher
Ulyanovsk State University
Reference38 articles.
1. Belenkov Yu.N., Privalova E.V., Kaplunova V.Yu., Zektser V.Yu., Vinogradova N.N., Il'gisonis I.S., Shakar'yants G.A., Kozhevnikova M.V., Lishuta A.S. Metabolicheskiy sindrom: istoriya razvitiya, osnovnye kriterii diagnostiki [Metabolic syndrome: History of development and main diagnostic criteria]. Ratsional'naya farmakoterapiya v kardiologii. 2018; 14 (5): 757–764 (in Russian).
2. Oganov R.G., Denisov I.N., Simanenkov V.I., Bakulin I.G., Bakulina N.V., Boldueva S.A., Barbarash O.N., Garganeeva N.P., Doshchitsin V.L., Drapkina O.M., Dudinskaya E.N., Kotovskaya Yu.V., Lila A.M., Mamedov M.N., Mardanov B.U., Miller O.N., Petrova M.M., Pozdnyakov Yu.M., Runikhina N.K., Sayganov S.A., Tarasov A.V., Tkacheva O.N., Urinskiy A.M., Shal'nova S.A. Komorbidnaya patologiya v klinicheskoy praktike. Klinicheskie rekomendatsii [Comorbid pathology in clinical practice. Clinical guidelines]. Kardiovaskulyarnaya terapiya i profilaktika. 2017; 16 (6): 5–56 (in Russian).
3. Oganov R.G., Simanenkov V.I., Bakulin I.G., Bakulina N.V., Barbarash O.L., Boytsov S.A., Boldueva S.A., Garganeeva N.P., Doshchitsin V.L., Karateev A.E., Kotovskaya Yu.V., Lila A.M., Luk'yanov M.M., Morozova T.E., Pereverzev A.P., Petrova M.M., Pozdnyakov Yu.M., Syrov A.V., Tarasov A.V., Tkacheva O.N., Shal'nova S.A. Komorbidnaya patologiya v klinicheskoy praktike. Algoritmy diagnostiki i lecheniya [Comorbid pathology in clinical practice. Algorithms for diagnosis and treatment]. Kardiovaskulyarnaya terapiya i profilaktika. 2019; 18 (1): 5–66 (in Russian).
4. Babenko A.Yu., Laevskaya M.Yu. Nealkogol'naya zhirovaya bolezn' pecheni – vzaimosvyazi s metabolicheskim sindromom [Non-alcoholic fatty liver disease: Correlation with metabolic syndrome]. Russkiy meditsinskiy zhurnal. 2018; 1 (I): 34–40. Available at: https://www.rmj.ru/articles/endokrinologiya/Nealkogolynaya_ghirovaya_bolezny_pecheni_vzaimosvyazi_s_metabolicheskim_sindromom/#ixzz872Tqf2roUnder Creative Commons License: Attribution (accessed: March 23, 2023) (in Russian).
5. Livzan M.A., Gaus O.V., Nikolaev N.A., Krolevets T.S. NAZhBP: komorbidnost' i assotsiirovannye zabolevaniya [NAFLD: Comorbidity and associated diseases]. Eksperimental'naya i klinicheskaya gastroenterologiya. 2019; 1 (10): 57–65 (in Russian).